TrialThe Journal of clinical endocrinology and metabolism2014

Anatabine supplementation decreases thyroglobulin antibodies in patients with chronic lymphocytic autoimmune (Hashimoto's) thyroiditis: a randomized controlled clinical trial.

Lowell R Schmeltz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.